TRANSCRIPTA Trademark

Trademark Overview

On Saturday, May 25, 2024, a trademark application was filed for TRANSCRIPTA with the United States Patent and Trademark Office. The USPTO has given the TRANSCRIPTA trademark a serial number of 98569148. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 28, 2025. This trademark is owned by Transcripta Bio, Inc.. The TRANSCRIPTA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, biotechnology, and medical research and development services; medical testing services, namely, blood, cell and/or tissue sample preparation and testing; developing potential therapies and interventions in the field of rare diseases, namely, development of pharmaceutical compounds, cell- and gene therapies, antibodies, personalized medicine, drug repurposing; performing medical nonclinical and clinical research in the field of rare diseases
transcripta

General Information

Serial Number98569148
Word MarkTRANSCRIPTA
Filing DateSaturday, May 25, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements

Goods and ServicesScientific, biotechnology, and medical research and development services; medical testing services, namely, blood, cell and/or tissue sample preparation and testing; developing potential therapies and interventions in the field of rare diseases, namely, development of pharmaceutical compounds, cell- and gene therapies, antibodies, personalized medicine, drug repurposing; performing medical nonclinical and clinical research in the field of rare diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 25, 2024
Primary Code042
First Use Anywhere DateSunday, March 31, 2024
First Use In Commerce DateSunday, March 31, 2024

Trademark Owner History

Party NameTranscripta Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94303
Party NameTranscripta Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94303

Trademark Events

Event DateEvent Description
Thursday, November 7, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, November 7, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, May 25, 2024NEW APPLICATION ENTERED
Tuesday, December 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 9, 2024ASSIGNED TO EXAMINER
Tuesday, December 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 18, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 10, 2024NON-FINAL ACTION WRITTEN
Tuesday, December 10, 2024NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, December 18, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, December 19, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, December 19, 2024ATTORNEY REVIEW COMPLETED
Thursday, December 19, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, December 19, 2024REVIEW OF CORRESPONDENCE COMPLETE
Friday, December 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 20, 2024NON-FINAL ACTION WRITTEN
Friday, December 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 27, 2024ASSIGNED TO LIE
Thursday, January 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 2, 2025PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 20, 2024NON-FINAL ACTION E-MAILED

Related Keywords

transcripta medical cell field rare namely diseases therapies testing development research